<DOC>
	<DOCNO>NCT00317434</DOCNO>
	<brief_summary>The purpose study determine maximum tolerate dose Lapatinib Carboplatin AUC 6 patient platinum sensitive recurrent ovarian primary peritoneal carcinoma determine nature degree toxicity Lapatinib combination carboplatin AUC 6 cohort patient .</brief_summary>
	<brief_title>Maximum Tolerated Dose Lapatinib When Given With Carboplatin Recurrent Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Lapatinib</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologic diagnosis epithelial ovarian primary peritoneal cancer Measurable disease evaluable disease CA125 &gt; 100 One prior treatment taxane/platinum base chemotherapy , patient recurrent ovarian cancer receive platinumbased chemotherapy time initial diagnosis allow Recurrence treatment free interval least 6 mos completion primary chemotherapy 19 year age old Life expectancy great 12 week Performance status 0 , 1 2 ( base GOG Performance Status ) Normal bone marrow , renal hepatic function base upon lab test Cardiac ejection fraction within institutional normal range Ability swallow retain oral medication Ability understand write informed consent document Patients chemotherapy radiotherapy within 4 week prior enter study Epithelial ovarian tumor low malignant potential , stromal germ cell origin Nonmeasurable nonevaluable disease Archived tumor tissue available assay Patients may receive investigational agent concurrent anticancer therapy , herbal ( alternative ) medicine Patients know brain metastasis History allergic reaction attribute compound similar chemical biologic composition study agent . Uncontrolled intercurrent illness Patients pregnant HIVpositive patient receive combination antiretroviral therapy Patients GI tract disease result inability take oral medication</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>ovarian cancer</keyword>
</DOC>